RNAi tools
Dharmacon, a US supplier of RNA and RNA-interference research products, announced today it has launched Cell Cycle siARRAY, a collection of ready-to-use siRNA duplexes designed to knock down 112 genes involved in cell cycle regulation.
Dharmacon, a US supplier of RNA and RNA-interference research products, announced today it has launched Cell Cycle siARRAY, a collection of ready-to-use siRNA duplexes designed to knock down 112 genes involved in cell cycle regulation.
British Biotech, once the darling of the UK biotechnology industry but now suffering the after-effects of a string of major drug development failures, is having another go at bolstering its pipeline via a merger with fellow UK company RiboTargets in...
Ireland's Elan Corp has inked a deal with Ingenium Pharmaceuticals of Germany that will see the companies apply Ingenium's functional genomics technologies to the discovery and development of novel therapeutics for pain management, one of Elan's core...
Venture capital investments in biotechnology and medical device companies combined to total $4.7 billion (€4.4bn) in 2002, or 22 per cent of all investing, representing the highest proportion in seven years, according to the MoneyTree survey from...